Analyst consensus rating
Foghorn Therapeutics Inc. Analyst Consensus Rating
FHTX analyst consensus rating, coverage count and price target evidence.
Direct answer
Foghorn Therapeutics Inc.'s consensus rating is Strong Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $11.44.
Forecast evidence checked August 11, 2026.
Get free Foghorn Therapeutics Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.51
- Average price target
- $11.44
- High price target
- $14.00
- Low price target
- $9.00
- Target upside
- +75.9%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- August 11, 2026
- Valid through
- August 18, 2026